【24h】

The role of radiotherapy in treating small early invasive breast cancer.

机译:放射疗法在治疗小型早期浸润性乳腺癌中的作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIM: The aim of the study was to identify if radiotherapy can be safely avoided in a selected subgroup of largely screening detected small invasive breast cancer. METHODS: One hundred and eighty-eight patients with node negative invasive early breast cancer < or =1cm (< or =T1b) treated in our centre between 1990 and 2004 were retrospectively followed for local, regional and distant recurrences. Treatment involved adequate local excision by breast conserving surgery (BCS). Axillary staging was performed by a four node axillary sampling until 2000, following which sentinel lymph node sampling was employed. All sections were assessed histologically by haematoxylin and eosin stained sections. The inked margins were reported as being involved, close and clear. Radiotherapy (RT) was employed only if the resected margins were inadequate, and in those with involved axillary nodes who refused further completion axillary clearance. RESULTS: Ninety-four patients (Group A) had BCS alone and 79 patients (Group B) had both BCS and RT. There was no ipsilateral breast tumour recurrence (IBTR) in 88 patients in Group A, corresponding to an actuarial freedom from IBTR of 96%, 91% and 88.1% at 5 years, 8 years and 9 years. In Group B, there was no IBTR in 75 patients corresponding to an actuarial freedom from IBTR of 97%, 94.9% and 90.6% at 5 years, 8 years and 10 years. CONCLUSION: Our experience over 14 years has shown that it is possible to safely avoid radiotherapy in a selected subgroup of small invasive breast cancer.
机译:目的:该研究的目的是确定在很大程度上筛查检测到的小浸润性乳腺癌的选定亚组中,是否可以安全地避免放疗。方法:回顾性分析1990年至2004年间在我中心接受治疗的188例淋巴结阴性浸润性早期乳腺癌<或= 1cm(<或= T1b)患者的局部,区域和远处复发情况。治疗包括通过保乳手术(BCS)进行足够的局部切除。通过四结点腋窝取样进行腋窝分期直至2000年,之后采用前哨淋巴结取样。通过苏木精和曙红染色的切片在组织学上评估所有切片。据报道,墨迹边距紧密,清晰。仅在切除的切缘不充分时,以及在腋窝淋巴结转移而拒绝进一步完成腋窝清除的患者中,才采用放射疗法。结果:94例患者(A组)单独接受BCS治疗,而79例患者(B组)同时接受BCS和RT治疗。 A组88例患者无同侧乳腺肿瘤复发(IBTR),在5年,8年和9年时,相应的IBTR精算自由度分别为96%,91%和88.1%。在B组中,有75名患者没有IBTR,在5年,8年和10年时,其IBTR的精算自由度分别为97%,94.9%和90.6%。结论:我们超过14年的经验表明,在选定的小浸润性乳腺癌亚组中可以安全地避免放疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号